Clinical Site

Calgary T2N 4L7

1 studies enrolling now · 3 studies all time

What they study most

Arthritis, Psoriatic, C3 Glomerulopathy (C3G)

Studies at this site

• Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response — Recruiting now
• Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug — Running, not enrolling
• Controlled Trial Evaluating Avacopan in C3 Glomerulopathy — Completed